Angel One - Share Market Trading and Stock Broking
LoginOpen Demat Account
Skip to main content
Corbus Pharmaceuticals Holdings, Inc. logo

Corbus Pharmaceuticals Holdings, Inc. Share Price

NASDAQ: CRBPHealthcare

$5.18

-0.07 (1.33%)
BUYSELL

Live Corbus Pharmaceuticals Holdings, Inc. Share Price Chart

O H L

Corbus Pharmaceuticals Holdings, Inc. Performance Overview

Days Range
▼
$5.20Low
$5.40High

Markets Today

Previous Close$5.27
Open$5.25
Volume114,169
Day's Range$5.20 - $5.40
52W Range$5.47 - $20.56
Market Cap$106.18 M

Historical Performance

1M Returns-40.52
3M Returns-45.45
6M Returns-48.93
1Y Returns-66.43
5Y Returns-82.94
10Y Returns-98.16

Corbus Pharmaceuticals Holdings, Inc. Fundamentals

Market Cap$106.18 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-0.54
EPS TTM$-6.17
Quarterly Earnings Growth YOYN/A
PB Ratio1.00
EBITDA$-85.08 M
Profit MarginN/A
Market Cap$106.18 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-0.54
EPS TTM$-6.17
Quarterly Earnings Growth YOYN/A
PB Ratio1.00
EBITDA$-85.08 M
Profit MarginN/A

Corbus Pharmaceuticals Holdings, Inc. Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$0$0$0$0$0$0
Gross Profit +$0$0$0$0$0$0
Operating Income -$19.77 M-$19.15 M-$24.42 M-$21.97 M-$24.30 M-$36.19 M
EBITDA -$19.69 M-$19.10 M-$24.37 M-$21.92 M-$24.25 M-$36.14 M
Interest Expense $0$0$0$0$0$0
Depreciation $81.00 K$53.00 K$50.00 K$49.00 K$49.00 K$51.00 K
Income Before Tax -$16.98 M-$17.66 M-$23.34 M-$20.55 M-$22.97 M-$35.04 M
Income Tax Expense $0$0$0$0$0$0
Net Income +-$16.98 M-$17.66 M-$23.34 M-$20.55 M-$22.97 M-$35.04 M
Net Profit Margin ------

Corbus Pharmaceuticals Holdings, Inc. Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $1.00 K$1.00 K$1.00 K$2.00 K$2.00 K$2.00 K
Reserve & Surplus -$493.89 M-$511.57 M-$534.88 M-$555.48 M-$578.56 M-$613.54 M
Non-Current Liabilities $1.21 M$761.00 K$307.00 K$0$0$3.27 M
Current Liabilities $11.62 M$13.33 M$17.06 M$20.69 M$18.14 M$21.48 M
Total Liabilities $12.82 M$14.09 M$17.37 M$20.69 M$18.14 M$24.75 M
Fixed Assets $304.00 K$251.00 K$201.00 K$159.00 K$116.00 K$71.00 K
Current Assets $137.36 M$122.83 M$107.57 M$166.95 M$143.57 M$122.75 M
Total Assets $139.93 M$125.08 M$109.51 M$168.19 M$144.48 M$126.99 M

Corbus Pharmaceuticals Holdings, Inc. Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$16.98 M-$17.66 M-$23.34 M-$20.55 M-$22.97 M-$35.04 M
Operating Cash Flow -$16.42 M-$16.60 M-$15.55 M-$15.92 M-$25.57 M-$29.63 M
Investing Cash Flow $18.12 M$17.74 M$19.64 M-$57.15 M$22.45 M$18.26 M
Financing Cash Flow $0$0$2.85 M$74.58 M$0$9.07 M
Change in Cash $1.70 M$1.14 M$6.94 M$1.51 M-$3.12 M-$2.29 M

Corbus Pharmaceuticals Holdings, Inc. Return Calculator

The Corbus Pharmaceuticals Holdings, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$1,676
Invested Amount$10,000
Est. Returns$-8,324
Invest in USA Stock Today

About Corbus Pharmaceuticals Holdings, Inc.

Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

FAQs

Corbus Pharmaceuticals Holdings, Inc. (CRBP) share price as of October 9, 2026 is $5.18. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Corbus Pharmaceuticals Holdings, Inc. (CRBP) Share by opening an international trading account with Angel One.
Purchasing Corbus Pharmaceuticals Holdings, Inc. (CRBP) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Corbus Pharmaceuticals Holdings, Inc. (CRBP) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Corbus Pharmaceuticals Holdings, Inc. (CRBP) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Corbus Pharmaceuticals Holdings, Inc. on October 9, 2026, is $106.18 M.
Corbus Pharmaceuticals Holdings, Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Corbus Pharmaceuticals Holdings, Inc. (CRBP) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Want to open an NRI account?
Top US Stocks

VIEW ALL